HeartSciences Inc.(HSCS)

$2.44—Earnings today

Chart

HeartSciences Inc.(HSCS)

NASDAQ

$2.44—Earnings today

Chart Studio

HSCS(HSCS)

HSCS

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.66

Jul 23, 2026 · Reports before open

Revenue Estimate

$50,000

Analyst Sentiment

Wall St. Consensus

Buy

3 analysts·Low coverage

Score

3 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

3100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$3.00

+23.0%

Consensus

$3.00

+23.0%

Bull

$3.00

+23.0%

12-Month Target Range3 analysts

$3.00$3.00$3.00

Current $2.44Consensus

Current Price

$2.44

Upside to Consensus

$0.56

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+600.00%

EPS—

FY2028

Rev+814.29%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2027E	FY2028E
Revenue Avg	$350,000	$3M
Low	$236,643	$3M
High	$463,356	$3M
EBITDA Avg	$-350,000	$-3M
Low	$-463,356	$-3M
High	$-236,643	$-3M
EBIT Avg	$-350,000	$-3M
Low	$-463,356	$-3M
High	$-236,643	$-3M
Net Income Avg	$-3M	$-2M
Low	$-4M	$-3M
High	$-2M	$-1M
EPS Avg	$-3.02	$-2.21
Low	$-4.28	$-3.14
High	$-1.75	$-1.28
Analysts (Rev / EPS)	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$100,000	$100,000	$200,000	$300,000	$100,000	$100,000	$1M	$2M
Low	$100,000	$100,000	$200,000	$300,000	$100,000	$100,000	$1M	$2M
High	$100,000	$100,000	$200,000	$300,000	$100,000	$100,000	$1M	$2M
EBITDA Avg	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
Low	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
High	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
EBIT Avg	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
Low	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
High	$-100,000	$-100,000	$-200,000	$-300,000	$-100,000	$-100,000	$-1M	$-2M
Net Income Avg	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-885,432
Low	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-885,432
High	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-885,432
EPS Avg	$-0.70	$-0.63	$-0.64	$-0.58	$-0.64	$-0.59	$-0.43	$-0.28
Low	$-0.74	$-0.63	$-0.64	$-0.58	$-0.64	$-0.59	$-0.43	$-0.28
High	$-0.66	$-0.63	$-0.64	$-0.58	$-0.64	$-0.59	$-0.43	$-0.28
Analysts (Rev / EPS)	1 / 2	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Dec 19, 2022Maxim Group

Maxim Group Maintains Buy on Heart Test Laboratories, Lowers Price Target to $3

Target:$3.00

+233.3%from $0.90

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance